1. Sci Adv. 2015 Nov 13;1(10):e1500723. doi: 10.1126/sciadv.1500723. eCollection 
2015 Nov.

Selective targeting of the BRG/PB1 bromodomains impairs embryonic and 
trophoblast stem cell maintenance.

Fedorov O(1), Castex J(2), Tallant C(1), Owen DR(3), Martin S(1), Aldeghi M(4), 
Monteiro O(1), Filippakopoulos P(5), Picaud S(6), Trzupek JD(3), Gerstenberger 
BS(3), Bountra C(1), Willmann D(2), Wells C(1), Philpott M(1), Rogers C(1), 
Biggin PC(7), Brennan PE(1), Bunnage ME(3), Schüle R(8), Günther T(2), Knapp 
S(9), Müller S(1).

Author information:
(1)Target Discovery Institute, University of Oxford, NDM Research Building, 
Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, 
University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford 
OX3 7DQ, UK.
(2)Urologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität 
Freiburg, Breisacher Strasse 66, 79106 Freiburg, Germany.
(3)Pfizer Worldwide Medicinal Chemistry, 610 Main Street, Cambridge, MA 02139, 
USA.
(4)Target Discovery Institute, University of Oxford, NDM Research Building, 
Roosevelt Drive, Oxford OX3 7FZ, UK. ; Department of Biochemistry, University of 
Oxford, South Parks Road, Oxford OX1 3QU, UK.
(5)Structural Genomics Consortium, University of Oxford, Old Road Campus 
Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK. ; Ludwig Institute for 
Cancer Research, University of Oxford, Oxford OX3 7DQ, UK.
(6)Structural Genomics Consortium, University of Oxford, Old Road Campus 
Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.
(7)Department of Biochemistry, University of Oxford, South Parks Road, Oxford 
OX1 3QU, UK.
(8)Urologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität 
Freiburg, Breisacher Strasse 66, 79106 Freiburg, Germany. ; Deutsches Konsortium 
für Translationale Krebsforschung, Standort Freiburg, 79106 Freiburg, Germany. ; 
Institute for Pharmaceutical Chemistry and Buchmann Institute for Molecular Life 
Sciences, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 9, D-60438 
Frankfurt am Main, Germany.
(9)Target Discovery Institute, University of Oxford, NDM Research Building, 
Roosevelt Drive, Oxford OX3 7FZ, UK. ; Structural Genomics Consortium, 
University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford 
OX3 7DQ, UK. ; Institute for Pharmaceutical Chemistry and Buchmann Institute for 
Molecular Life Sciences, Johann Wolfgang Goethe-University, Max-von-Laue-Str. 9, 
D-60438 Frankfurt am Main, Germany.

Mammalian SWI/SNF [also called Brg/Brahma-associated factors (BAFs)] are 
evolutionarily conserved chromatin-remodeling complexes regulating gene 
transcription programs during development and stem cell differentiation. BAF 
complexes contain an ATP (adenosine 5'-triphosphate)-driven remodeling enzyme 
(either BRG1 or BRM) and multiple protein interaction domains including 
bromodomains, an evolutionary conserved acetyl lysine-dependent protein 
interaction motif that recruits transcriptional regulators to acetylated 
chromatin. We report a potent and cell active protein interaction inhibitor, 
PFI-3, that selectively binds to essential BAF bromodomains. The high 
specificity of PFI-3 was achieved on the basis of a novel binding mode of a 
salicylic acid head group that led to the replacement of water molecules 
typically maintained in other bromodomain inhibitor complexes. We show that 
exposure of embryonic stem cells to PFI-3 led to deprivation of stemness and 
deregulated lineage specification. Furthermore, differentiation of trophoblast 
stem cells in the presence of PFI-3 was markedly enhanced. The data present a 
key function of BAF bromodomains in stem cell maintenance and differentiation, 
introducing a novel versatile chemical probe for studies on 
acetylation-dependent cellular processes controlled by BAF remodeling complexes.

DOI: 10.1126/sciadv.1500723
PMCID: PMC4681344
PMID: 26702435